Voloridge Investment Management, LLC Pacira Bio Sciences, Inc. Transaction History

Voloridge Investment Management, LLC

$26.2 Billion
Q3 2024

A detailed history of Voloridge Investment Management, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Voloridge Investment Management, LLC holds 50,682 shares of PCRX stock, worth $829,664. This represents 0.0% of its overall portfolio holdings.

Number of Shares

50,682

Previous 64,667 21.63%

Holding current value

$829,664

Previous $1.85 Million 58.76%

% of portfolio

0.0%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$11.7 - $28.46 $163,624 - $398,013	-13,985 Reduced 21.63%	50,682 $763,000
Q2 2024 Aug 14, 2024	SELL	$25.5 - $31.51 $3.16 Million - $3.9 Million	-123,777 Reduced 65.68%	64,667 $1.85 Million
Q1 2024 May 15, 2024	BUY	$27.7 - $35.48 $3.16 Million - $4.04 Million	113,990 Added 153.1%	188,444 $5.51 Million
Q4 2023 Feb 14, 2024	BUY	$26.32 - $34.31 $1.05 Million - $1.37 Million	40,044 Added 116.37%	74,454 $2.51 Million
Q3 2023 Nov 14, 2023	BUY	$30.68 - $40.09 $1.06 Million - $1.38 Million	34,410 New	34,410 $1.06 Million
Q4 2021 Feb 14, 2022	SELL	$47.97 - $62.21 $3.88 Million - $5.03 Million	-80,849 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$54.64 - $61.3 $2.54 Million - $2.85 Million	46,562 Added 135.8%	80,849 $4.53 Million
Q2 2021 Aug 16, 2021	BUY	$59.18 - $69.99 $1.8 Million - $2.13 Million	30,481 Added 800.87%	34,287 $2.08 Million
Q1 2021 May 17, 2021	SELL	$59.31 - $78.82 $6.52 Million - $8.66 Million	-109,886 Reduced 96.65%	3,806 $267,000
Q4 2020 Feb 16, 2021	BUY	$50.47 - $66.26 $163,270 - $214,351	3,235 Added 2.93%	113,692 $6.8 Million
Q3 2020 Nov 16, 2020	BUY	$51.97 - $63.0 $5.74 Million - $6.96 Million	110,457 New	110,457 $6.64 Million
Q1 2020 May 15, 2020	SELL	$28.4 - $50.7 $213,369 - $380,909	-7,513 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$36.31 - $46.83 $272,797 - $351,833	7,513 New	7,513 $340,000
Q2 2019 Aug 14, 2019	SELL	$36.57 - $47.97 $545,002 - $714,896	-14,903 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$36.47 - $42.17 $449,055 - $519,239	-12,313 Reduced 45.24%	14,903 $567,000
Q4 2018 Feb 14, 2019	SELL	$41.31 - $52.16 $1.19 Million - $1.51 Million	-28,910 Reduced 51.51%	27,216 $1.17 Million
Q3 2018 Nov 14, 2018	BUY	$32.85 - $52.0 $1.84 Million - $2.92 Million	56,126 New	56,126 $2.76 Million

Others Institutions Holding PCRX

# of Institutions

266

Shares Held

50.7M

Call Options Held

347K

Put Options Held

391K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $750M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voloridge Investment Management, LLC with notifications on news.

Account

Voloridge Investment Management, LLC Pacira Bio Sciences, Inc. Transaction History